IMMUNE-MEDIATED NEUROLOGICAL DISORDER

IMMUNE-MEDIATED NEUROLOGICAL DISORDER was reported 87 times

These drug classes are most commonly taken by patients reporting IMMUNE-MEDIATED NEUROLOGICAL DISORDER:

# Drug Count
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 74
1 CTLA-4-directed Blocking Antibody [EPC] 18
2 Platinum-based Drug [EPC] 17
3 Microtubule Inhibitor [EPC] 10
4 Programmed Death Ligand-1 Blocker [EPC] 5
5 Proton Pump Inhibitor [EPC] 5
6 Tumor Necrosis Factor Blocker [EPC] 5
7 Corticosteroid [EPC] 4
8 Nonsteroidal Anti-inflammatory Drug [EPC] 4
9 Alkylating Drug [EPC] 2
10 Kinase Inhibitor [EPC] 2
11 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
12 Peroxisome Proliferator Receptor gamma Agonist [EPC] 2
13 Platelet Aggregation Inhibitor [EPC] 2
14 Thiazolidinedione [EPC] 2
15 Vascular Endothelial Growth Factor Inhibitor [EPC] 2
16 5-alpha Reductase Inhibitor [EPC] 1
17 Aminosalicylate [EPC] 1
18 Anti-IgE [EPC] 1
19 Antimalarial [EPC] 1
20 Antiprotozoal [EPC] 1
21 Arteriolar Vasodilator [EPC] 1
22 Benzodiazepine [EPC] 1
23 CD20-directed Cytolytic Antibody [EPC] 1
24 Calcium Channel Blocker [EPC] 1
25 Carbonic Anhydrase Inhibitor [EPC] 1
26 Catecholamine [EPC] 1
27 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
28 Dihydropyridine Calcium Channel Blocker [EPC] 1
29 Expectorant [EPC] 1
30 Glinide [EPC] 1
31 Glycopeptide Antibacterial [EPC] 1
32 Histamine-1 Receptor Antagonist [EPC] 1
33 Human Immunoglobulin G [EPC] 1
34 Non-narcotic Antitussive [EPC] 1
35 Nucleoside Metabolic Inhibitor [EPC] 1
36 Opioid Agonist [EPC] 1
37 Orexin Receptor Antagonist [EPC] 1
38 Osmotic Laxative [EPC] 1
39 Prostaglandin Analog [EPC] 1
40 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
41 alpha-Adrenergic Agonist [EPC] 1
42 beta-Adrenergic Agonist [EPC] 1
43 beta-Adrenergic Blocker [EPC] 1